101 related articles for article (PubMed ID: 7092178)
1. Taurine and hyperexcitable human muscle: effects of taurine on potassium-induced hyperexcitability of dystrophic myotonic and normal muscles.
Durelli L; Mutani R; Fassio F; Satta A; Bartoli E
Ann Neurol; 1982 Mar; 11(3):258-65. PubMed ID: 7092178
[TBL] [Abstract][Full Text] [Related]
2. The effects of the increase of arterial potassium upon the excitability of normal and dystrophic myotonic muscles in man.
Durelli L; Mutani R; Fassio F; Delsedime M
J Neurol Sci; 1982 Sep; 55(3):249-57. PubMed ID: 7131034
[TBL] [Abstract][Full Text] [Related]
3. Myotonia, potassium and taurine. A preliminary report.
Durelli L; Mutani R
J Neurol Sci; 1979 Jun; 42(1):103-9. PubMed ID: 448391
[TBL] [Abstract][Full Text] [Related]
4. Normalization of muscle transmembrane ionic fluxes induced by taurine in patients affected with myotonic dystrophy.
Mutani R; Durelli L; Piredda S
Acta Neurol Belg; 1982; 82(3):122-7. PubMed ID: 6287791
[No Abstract] [Full Text] [Related]
5. Ion content, potassium efflux and cable properties of myotonic, human, external-intercostal muscle.
Lipicky RJ; Bryant SH
Trans Am Neurol Assoc; 1971; 96():34-8. PubMed ID: 5159127
[No Abstract] [Full Text] [Related]
6. Expression of apamin receptor in muscles of patients with myotonic muscular dystrophy.
Renaud JF; Desnuelle C; Schmid-Antomarchi H; Hugues M; Serratrice G; Lazdunski M
Nature; 1986 Feb 20-26; 319(6055):678-80. PubMed ID: 2419758
[TBL] [Abstract][Full Text] [Related]
7. The effects of taurine on pharmacologically induced myotonia.
Conte Camerino D; De Luca A; Mambrini M; Ferrannini E; Franconi F; Giotti A; Bryant SH
Muscle Nerve; 1989 Nov; 12(11):898-904. PubMed ID: 2608084
[TBL] [Abstract][Full Text] [Related]
8. Possible role of apamin-sensitive K+ channels in myotonic dystrophy.
Behrens MI; Jalil P; Serani A; Vergara F; Alvarez O
Muscle Nerve; 1994 Nov; 17(11):1264-70. PubMed ID: 7935548
[TBL] [Abstract][Full Text] [Related]
9. [Fatigue at various muscular lengths in myotonic dystrophy].
Siciliano G; Diverio M; Rosellini P; Rossi B
Riv Neurol; 1991; 61(5):191-6. PubMed ID: 1808679
[TBL] [Abstract][Full Text] [Related]
10. Potassium concentration changes in the transverse tubules of vertebrate skeletal muscle.
Almers W
Fed Proc; 1980 Apr; 39(5):1527-32. PubMed ID: 7364047
[TBL] [Abstract][Full Text] [Related]
11. Vascular adrenergic receptor responses in skeletal muscle in myotonic dystrophy.
Mechler F; Mastaglia FL
Ann Neurol; 1981 Feb; 9(2):157-62. PubMed ID: 7235630
[TBL] [Abstract][Full Text] [Related]
12. Enhanced dystrophic progression in mdx mice by exercise and beneficial effects of taurine and insulin-like growth factor-1.
De Luca A; Pierno S; Liantonio A; Cetrone M; Camerino C; Fraysse B; Mirabella M; Servidei S; Rüegg UT; Conte Camerino D
J Pharmacol Exp Ther; 2003 Jan; 304(1):453-63. PubMed ID: 12490622
[TBL] [Abstract][Full Text] [Related]
13. Intracellular concentration of elements in normal and dystrophic skeletal muscles of the chicken.
Misra LK; Smith NK; Chang DC; Sparks RL; Cameron IL; Beall PT; Harrist R; Nichols BL; Fanguy RC; Hazlewood CF
J Cell Physiol; 1980 May; 103(2):193-200. PubMed ID: 7440632
[TBL] [Abstract][Full Text] [Related]
14. The effects of digoxin on resting membrane potentials of skeletal muscles in dystrophic mice.
Saito K; Ohkura H; Tanaka H; Kashima T; Katanasako H; Kanehisa T
Jpn J Exp Med; 1980 Jun; 50(3):179-82. PubMed ID: 7431675
[TBL] [Abstract][Full Text] [Related]
15. Chronic administration of taurine to aged rats improves the electrical and contractile properties of skeletal muscle fibers.
Pierno S; De Luca A; Camerino C; Huxtable RJ; Camerino DC
J Pharmacol Exp Ther; 1998 Sep; 286(3):1183-90. PubMed ID: 9732377
[TBL] [Abstract][Full Text] [Related]
16. Muscle histopathology in myotonic dystrophy in relation to age and muscular weakness.
Tohgi H; Kawamorita A; Utsugisawa K; Yamagata M; Sano M
Muscle Nerve; 1994 Sep; 17(9):1037-43. PubMed ID: 8065390
[TBL] [Abstract][Full Text] [Related]
17. Muscle taurine in chicken and diseased human muscle.
Airaksinen EM; Partanen J
Prog Clin Biol Res; 1985; 179():407-12. PubMed ID: 4059221
[No Abstract] [Full Text] [Related]
18. [Pseudohyperkalemia in myotonic dystrophy].
Nakazato Y; Shimazu K; Tamura N; Irino S; Hamaguchi K
Rinsho Shinkeigaku; 1993 Oct; 33(10):1097-9. PubMed ID: 8293615
[TBL] [Abstract][Full Text] [Related]
19. The treatment of myotonia: evaluation of chronic oral taurine therapy.
Durelli L; Mutani R; Fassio F
Neurology; 1983 May; 33(5):599-603. PubMed ID: 6341873
[TBL] [Abstract][Full Text] [Related]
20. Myotonic dystrophy patients have larger CTG expansions in skeletal muscle than in leukocytes.
Thornton CA; Johnson K; Moxley RT
Ann Neurol; 1994 Jan; 35(1):104-7. PubMed ID: 8285579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
